
Gary Luker, MD appointed as Faculty Director of the Microscopy Core
Karl Jepsen, M.D., Ph.D., associate dean for research, recently announced the appointment of
Karl Jepsen, M.D., Ph.D., associate dean for research, recently announced the appointment of
Atonco, a French biotechnology company, and University of Michigan Health today announced a collaborative agreement to conduct a Phase 1-2a clinical study evaluating Atonco's ATO-101™ ([211At] At-anti-CA-IX antibody) targeted alpha therapy candidate in non-muscle invasive bladder cancer (NMIBC).
Research activities within Radiology and other medical departments has led to the development of a new anti-cancer agent published in Nature Communications. The publication describes a new drug candidate that is orally delivered and is absorbed in the gut directly into the lymphatic system. Development and demonstration of a “lymphatropic”
After receiving one of only six prototypes of the Siemens Healthineers Free.Max in the world, the Michigan Medicine Department of Radiology installed the low-field MRI scanner. The device has a reduced field strength of .55 Tesla, which lowers cost and could improve image quality in certain settings. The scanner also provides a step towards low
Discovery holds promise for developing urgently needed new therapies in serious lung disease